Zhang Jia Jia, Yamanaka Kazuya, Tang Xiaoyu, Moore Bradley S
Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California at San Diego, La Jolla, San Diego, CA, United States.
Department of Life Science and Technology, Kansai University, Osaka, Japan.
Methods Enzymol. 2019;621:87-110. doi: 10.1016/bs.mie.2019.02.026. Epub 2019 Mar 21.
Heterologous expression of natural product biosynthetic gene clusters (BGCs) is a robust approach not only to decipher biosynthetic logic behind natural product (NP) biosynthesis, but also to discover new chemicals from uncharacterized BGCs. This approach largely relies on techniques used for cloning large BGCs into suitable expression vectors. Recently, several whole-pathway direct cloning approaches, including full-length RecE-mediated recombination in Escherichia coli, Cas9-assisted in vitro assembly, and transformation-associated recombination (TAR) in Saccharomyces cerevisiae, have been developed to accelerate BGC isolation. In this chapter, we summarize a protocol for TAR cloning large NP BGCs, detailing the process of choosing TAR plasmids, designing pathway-specific TAR vectors, generating yeast spheroplasts, performing yeast transformation, and heterologously expressing BGCs in various host strains. We believe that the established platforms can accelerate the process of discovering new NPs, understanding NP biosynthetic logic, and engineering biosynthetic pathways.
天然产物生物合成基因簇(BGCs)的异源表达不仅是一种强大的方法,可用于解读天然产物(NP)生物合成背后的生物合成逻辑,还能从未经表征的BGCs中发现新的化学物质。这种方法很大程度上依赖于将大型BGCs克隆到合适表达载体的技术。最近,已经开发了几种全途径直接克隆方法,包括大肠杆菌中全长RecE介导的重组、Cas9辅助的体外组装以及酿酒酵母中的转化相关重组(TAR),以加速BGCs的分离。在本章中,我们总结了一种用于TAR克隆大型NP BGCs的方案,详细介绍了选择TAR质粒、设计途径特异性TAR载体、制备酵母原生质体、进行酵母转化以及在各种宿主菌株中异源表达BGCs的过程。我们相信,所建立的平台可以加速发现新NP、理解NP生物合成逻辑以及工程化生物合成途径的进程。